RNK Health Review
Best for: compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationship
RNK Health (myrnk.com) is a GLP-1 + longevity telehealth platform offering compounded tirzepatide, compounded semaglutide (injectable and oral), NAD+ (injectable, nasal, liposomal), sermorelin, enclomiphene, and a DNA Blueprint test panel. Medical operations are based in Des Moines, IA; pharmacy fulfillment is in Springville, UT.
Medium confidence · Last verified 2026-04-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
RNK Health is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
RNK Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded Tirzepatide (starting) | compounded | $297 |
| Compounded Semaglutide injectable (starting) | compounded | $197 |
| Compounded Semaglutide oral (starting) | compounded | $198 |
✓ Pros
- •Both injectable and oral compounded semaglutide formats — wider format optionality than most stub entries in the cluster
- •GLP-1 + longevity stack (NAD+, sermorelin, enclomiphene, DNA testing) lets one provider serve readers also interested in performance/longevity adjacencies
- •Pricing is publicly displayed — $297/mo tirzepatide, $197/mo injectable semaglutide, $198/mo oral semaglutide
✗ Cons
- •States served not enumerated on the public landing page — needs direct confirmation before any state-page placement
- •Pharmacy partner not publicly named beyond a Springville, UT fulfillment reference
- •Compounded only on the GLP-1 side — no FDA-approved Wegovy/Zepbound brand-name option
Ready to start with RNK Health?
Starting at $197/month. See current pricing and start your free consultation.
Sources & methodology
Our RNK Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to RNK Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with RNK Health?
Starting at $197/month. See current pricing and start your free consultation.